0001127602-15-011916.txt : 20150318
0001127602-15-011916.hdr.sgml : 20150318
20150318173959
ACCESSION NUMBER: 0001127602-15-011916
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150317
FILED AS OF DATE: 20150318
DATE AS OF CHANGE: 20150318
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ZACCARDELLI DAVID
CENTRAL INDEX KEY: 0001627642
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 15711048
MAIL ADDRESS:
STREET 1: 55 TW ALEXANDER DRIVE
STREET 2: PO BOX 14186
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2015-03-17
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001627642
ZACCARDELLI DAVID
C/O UNITED THERAPEUTICS CORP.
1040 SPRING STREET
SILVER SPRING
MD
20910
1
EVP & Chief Operating Officer
Common Stock
2015-03-17
4
M
0
4000
47.50
A
5153
D
Common Stock
2015-03-17
4
S
0
4000
177.34
D
1153
D
Share Tracking Award
47.50
2015-03-17
4
M
0
4000
0
D
2013-03-15
2022-03-15
Common Stock
4000
17500
D
Exercise of a cash-settled share tracking award pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
/s/ John S. Hess, Jr. under Power of Attorney
2015-03-18